Ameer B, James M O, Saleh J
University of Florida College of Pharmacy, Gainesville 32610.
Drug Chem Toxicol. 1992;15(2):161-75. doi: 10.3109/01480549209032297.
The antiviral drug zidovudine (ZDV) and the analgesic and antipyretic agent acetaminophen (AP) are both biotransformed in the liver of humans to ether glucuronides. A previous clinical trial of ZDV suggested the potential for a clinically significant interaction between AP and ZDV, probably based upon competing hepatic metabolism. To study the mechanism of this potential competition between AP and ZDV as substrates for uridine diphosphoglucuronyltransferase (UDPGT), enzyme kinetic studies were performed using rat liver microsome preparations. Cross inhibition studies demonstrated that AP glucuronidation was competitively inhibited by ZDV, while ZDV glucuronidation was slightly inhibited by AP in a noncompetitive interaction.
抗病毒药物齐多夫定(ZDV)和止痛退热剂对乙酰氨基酚(AP)在人体肝脏中均会生物转化为醚葡糖苷酸。先前一项关于ZDV的临床试验表明,AP与ZDV之间可能存在具有临床意义的相互作用,这可能是基于竞争性肝脏代谢。为了研究AP和ZDV作为尿苷二磷酸葡糖醛酸基转移酶(UDPGT)底物之间这种潜在竞争的机制,使用大鼠肝微粒体制剂进行了酶动力学研究。交叉抑制研究表明,ZDV竞争性抑制AP的葡糖醛酸化,而在非竞争性相互作用中,AP对ZDV的葡糖醛酸化有轻微抑制作用。